Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-142068

President and CEO acquired 86,476 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2016-09-15 Other acquisition +81,686 867,193 D: show line 1 in the form
Walker Neal President and CEO 2016-09-15 Other acquisition +4,790 871,983 D: show line 2 in the form
Loading xslF345X03/doc4.xml…